Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Maria Adelaide Calderazzo"'
Autor:
Aran Singanayagam, Nicholas Glanville, Jason L. Girkin, Yee Man Ching, Andrea Marcellini, James D. Porter, Marie Toussaint, Ross P. Walton, Lydia J. Finney, Julia Aniscenko, Jie Zhu, Maria-Belen Trujillo-Torralbo, Maria Adelaide Calderazzo, Chris Grainge, Su-Ling Loo, Punnam Chander Veerati, Prabuddha S. Pathinayake, Kristy S. Nichol, Andrew T. Reid, Phillip L. James, Roberto Solari, Peter A. B. Wark, Darryl A. Knight, Miriam F. Moffatt, William O. Cookson, Michael R. Edwards, Patrick Mallia, Nathan W. Bartlett, Sebastian L. Johnston
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-16 (2018)
Corticosteroid therapy is frequently used for chronic obstructive pulmonary disease (COPD) but its use is associated with increased risk of pneumonia. Here the authors show that corticosteroid use impairs innate and adaptive immunity to rhinovirus in
Externí odkaz:
https://doaj.org/article/8d63530adb10416897e7c8b0db9afbdb
Autor:
Andrea Gramegna, Francesco Amati, Leonardo Terranova, Giovanni Sotgiu, Paolo Tarsia, Daniela Miglietta, Maria Adelaide Calderazzo, Stefano Aliberti, Francesco Blasi
Publikováno v:
Respiratory Research, Vol 18, Iss 1, Pp 1-13 (2017)
Abstract The role of neutrophil elastase (NE) is poorly understood in bronchiectasis because of the lack of preclinical data and so most of the assumptions made about NE inhibitor potential benefit is based on data from CF. In this context, NE seems
Externí odkaz:
https://doaj.org/article/3173e7f3be7a43019e71e315df706597
Autor:
Joseph Footitt, Peter A. B. Wark, Aran Singanayagam, Maria-Belen Trujillo Torralbo, Sebastian L. Johnston, Nathan W. Bartlett, Kristy Nichol, Su-Ling Loo, Andrew T. Reid, Punnam Chander Veerati, Patrick Mallia, Jason Girkin, Christopher Grainge, Maria Adelaide Calderazzo, Lydia J. Finney, Prabuddha S. Pathinayake, Eteri Bakhsoliani
Publikováno v:
American Journal of Physiology-Lung Cellular and Molecular Physiology
L903
L893
Am J Physiol Lung Cell Mol Physiol
L903
L893
Am J Physiol Lung Cell Mol Physiol
Patients with frequent exacerbations represent a chronic obstructive pulmonary disease (COPD) subgroup requiring better treatment options. The aim of this study was to determine the innate immune mechanisms that underlie susceptibility to frequent ex
Autor:
Aran Singanayagam, Sebastian L. Johnston, Sarah L. Elkin, Patrick Mallia, Maria Adelaide Calderazzo, Vijay Padmanaban, Lydia J. Finney, Maria-Belen Trujillo-Torralbo, Tatiana Kebadze, Julia Aniscenko, Eteri Bakhsoliani
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 14:823-833
Purpose: COPD patients often do not report acute exacerbations to healthcare providers - unreported exacerbations. It is not known whether variances in symptoms, airway obstruction, aetiology and inflammatory responses account for differences in repo
Autor:
Pedro Mondejar-Lopez, Anna Zolin, Patricia W. Garcia-Marcos, Mª Dolores Pastor-Vivero, Maria Rosa-Silvestre, Francisco de Asis Sanchez-Martinez, Donatello Salvatore, Giuseppe Cimino, Fabio Majo, Amparo Sole-Jover, Oscar Asensio de la Cruz, Maria Adelaide Calderazzo, Giovanna Pizzamiglio, Silvia Castillo-Corullon, Antonio Alvarez-Fernandez, Silvia Gartner, Rita Padoan, Vincenzo Carnovale, Marco Salvatore, Mª Rosa Moya-Quiles, Annalisa Orenti, Guillermo Glover, Manuel Sanchez-Solis
Publikováno v:
RESPIRATORY MEDICINE
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Banco de España
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Banco de España
BACKGROUND: A1006E is a Cystic Fibrosis (CF) mutation that is still not widely known. We report phenotypic features and geographic distribution of the largest cohort of people with CF (pwCF) carrying A1006E to date. METHODS: Study of European pwCF ca
Autor:
Maria Belen Trujillo-Torralbo, Nathan W. Bartlett, Hugo Farne, Samuel V. Kemp, Su Ling Loo, Peter Fenwick, Aran Singanayagam, Sebastian L. Johnston, Patrick Mallia, Jadwiga A. Wedzicha, Nicholas Glanville, Maria Adelaide Calderazzo, Lydia J. Finney, Julia Aniscenko
Publikováno v:
The Journal of Allergy and Clinical Immunology
519.e5
Journal of Allergy and Clinical Immunology
519.e5
Journal of Allergy and Clinical Immunology
Background The mechanisms underlying altered susceptibility and propensity to severe Coronavirus disease 2019 (COVID-19) disease in at-risk groups such as patients with chronic obstructive pulmonary disease (COPD) are poorly understood. Inhaled corti
Autor:
Maria-Belen Trujillo-Torralbo, Peter Fenwick, Nicholas Glanville, Julia Aniscenko, Patrick Mallia, Sebastian L. Johnston, Maria Adelaide Calderazzo, Aran Singanayagam, Nathan W. Bartlett, Samuel V. Kemp, Jadwiga A. Wedzicha, Lydia J. Finney, Hugo Farne
Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is a new rapidly spreading infectious disease. Early reports of hospitalised COVID-19 cases have shown relatively low frequency of chronic lung diseases such as chronic obstructive pulmonary di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::714b04accc2f1171b51e193a375c7759
https://doi.org/10.1101/2020.06.13.149039
https://doi.org/10.1101/2020.06.13.149039
Autor:
Domenica De Venuto, Donatello Salvatore, Giovanna Pisi, Carlotta Biglia, Fabio Majo, Michela Francalanci, Federico Cresta, Giovanna Pizzamiglio, Maria Adelaide Calderazzo, Barbara Messore, Vito Terlizzi, Giuseppina Leonetti, Giovanni Taccetti, Mimma Caloiero
Publikováno v:
Respiratory medicine. 171
Background Ivacaftor is an innovative treatment for CF. Ivacaftor monotherapy in a phase III trial for patients with F508del and a residual function (RF) mutation showed improvement in lung function. We evaluated the effectiveness and safety of ivaca
Autor:
William O.C.M. Cookson, Maria-Belen Trujillo-Torralbo, Nicholas Glanville, Patrick Mallia, Phillip James, Elena M. Turek, Aran Singanayagam, Nathan W. Bartlett, Peter Fenwick, Eteri Bakhsoliani, Leah Cuthbertson, Maria Adelaide Calderazzo, Samuel V. Kemp, Lydia J. Finney, Thomas B. Clarke, Michael R. Edwards, Jadwiga A. Wedzicha, Joseph Footitt, Sebastian L. Johnston, Miriam F. Moffatt
Publikováno v:
Sci Transl Med
Bacterial infection commonly complicates inflammatory airway diseases such as chronic obstructive pulmonary disease (COPD). The mechanisms of increased infection susceptibility and how use of the commonly prescribed therapy inhaled corticosteroids (I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbb93cf723a7c0f847ce75e498258b4b
https://europepmc.org/articles/PMC7237237/
https://europepmc.org/articles/PMC7237237/
Autor:
Miriam F. Moffatt, Cross Mt, Joseph Footitt, Matthias Marczynski, Benjamin T. Käsdorf, Maria Adelaide Calderazzo, Patrick Mallia, W. Cookson, Trujillo Torralbo M, Nathan W. Bartlett, Thomas B. Clarke, Oliver Lieleg, Jingchun Zhu, PL Molyneaux, Lydia J. Finney, Sebastian L. Johnston, Aran Singanayagam, Juliya Aniscenko, Jadwiga A. Wedzicha, Christopher M. Evans
The respiratory tract surface is protected from inhaled pathogens by a secreted layer of mucus that is rich in mucin glycoproteins. Disrupted mucus production is a cardinal feature of chronic respiratory diseases but how this alteration affect intera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c99e5b7c70f13a876fb50ed639271c1a
https://doi.org/10.1101/706804
https://doi.org/10.1101/706804